E-Liquid clinical trials at UCSF
1 research study open to eligible people
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
open to eligible people ages 21-70
This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.
San Francisco, California and other locations
Our lead scientists for E-Liquid research studies include Neal Benowitz.